York, U.K., 7th February 2023: Abingdon Health plc (AIM: ABDX), a leading international developer, manufacturer and distributor of high quality and effective rapid tests, is pleased to announce the signing of a new distribution agreement with Salignostics for the launch of SalistickTM the first saliva-based pregnancy test in the UK and Ireland.
SalistickTM is a rapid saliva-based pregnancy test that offers women a new and improved user-experience, and high accuracy for early pregnancy detection. SalistickTM is based on Salignostics’ groundbreaking technology which detects the pregnancy hormone β-hCG in saliva. Traditional pregnancy tests are urine-based and SalistickTM offers the ability to test anywhere, at any time, and for the testing experience to be shared with a partner and other loved ones.
The Salignostics SalistickTM test is CE-marked and, subject to regulatory approval in the UK, is anticipated to be available in Q2-2023. SalistickTM will be co-branded Abingdon Simply Test and will be sold through Abingdon’s direct- to-consumer eCommerce platform and through Abingdon’s other pharmacy distribution channels.
Salignostics Ltd is an Israeli company that since 2016 has been developing cutting-edge technologies which transform saliva into a reliable body-fluid sample for lateral flow immunoassays like this β-hCG Pregnancy Rapid Test. The ingenuity of this technology lies in the ability to overcome physiological obstacles found in the chemical, biological and physical features of saliva. Salignostics’ method provides a revolutionary technological platform for saliva diagnostics across a wide range of possible uses.
The Abingdon Simply Test range now includes over 14 home use lateral flow self-tests which are sold direct-to-consumer through the Abingdon Simply Test website and Abingdon’s intention is to continue to expand the range of innovative self-tests it makes available to consumers through partnering with innovative companies, such as Salignostics, to offer the very best in novel self-test technology to the market.
Chris Yates, CEO of Abingdon Health plc, commented:
“We are delighted to be distributing SalistickTM in the UK and Ireland, the first saliva pregnancy test to be launched worldwide. This exciting innovation offers women the opportunity to test for pregnancy in a cleaner, more straightforward and easier way, and is a long overdue development in the pregnancy testing market. We are excited to be partnering with Salignostics and we look forward to continuing to work with them to bring innovative self-test products to market.’
Dr. Guy Krief, Co-Founder and Deputy CEO at Salignostics Ltd, had this to say:
“We are excited to join with Abingdon Health to bring our SalistickTM saliva-based pregnancy test to consumers in the UK and Ireland. We believe that Abingdon Health is the right partner to bring this revolutionary product to pharmacy shelves throughout the region, allowing for easy and accessible pregnancy tests for women.”
Enquiries
Abingdon Simply Test:
Liam Currivan
Distribution Channel Sales Manager
[email protected]
About Abingdon Health plc
Abingdon Simply Test is a direct-to-consumer ecommerce site that offers customers a range of lateral flow self-tests to empower individuals to manage their own health and wellbeing. Abingdon Simply Test ranges covers fertility, infectious disease and other wellbeing tests. Each test is approved for self-testing and has been independently reviewed and validated by Abingdon’s technical and regulatory experts. Abingdon Simply Test is a division of Abingdon Health plc, an AIM-listed (London Stock Exchange) group. Founded in 2008, Abingdon Health is headquartered in York, England. For more information visit: www.abingdonsimplytest.com; or www.abingdonhealth.com
